StonvexLoading…
StonvexCore line items from LYV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-06-30 |
|---|---|---|---|---|
Revenue | $25.20B | $23.16B | $22.73B | $8.75B |
Operating Income | $1.25B | $824.51M | $1.08B | $512.75M |
Net Income | $495.97M | $896.29M | $556.89M | $268.35M |
EPS (Diluted) | $-0.24 | $2.74 | $1.34 | $0.68 |
Total Assets | $22.91B | $19.64B | $19.03B | Not available |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $7.09B | $6.10B | $6.23B | Not available |
Free Cash Flow OCF − CapEx | $333.61M | $1.08B | $924.37M | Not available |
Shares Outstanding | 235.42M | 234.36M | 233.30M | Not available |